By analyzing the bioinformatics database and verifying the cancerous and non-cancerous tissues of different patients, we found a significant upregulation of CXCL13 and CCL20 in NSCLC versus normal lung tissue, establishing a tumor-directed chemokine gradient. This evidence concerns the gene CXCL13 and non-small cell lung carcinoma.